A comparison of nicotine delivery systems in a multimodality smoking cessation program

Article Abstract:

Patients using a nicotine patch in a smoking cessation program had a higher rate of quitting in the short term, fewer adverse reactions and more time before relapse compared to those using nicotine gum. Quit rates after one year were not significantly different for the two groups, however. None of the 17 patients using gum and two of the 21 using the patch continued to abstain from smoking after one year. Higher nicotine dependency was correlated with less time to relapse, but time to relapse was longer for the older participants, those aged 50 to 69.

Research, Smoking cessation programs, Transdermal medication, Smoking cessation, Transdermal drug delivery systems, Nicotine chewing gum

---

Prophylaxis for severe respiratory syncytial virus disease

Article Abstract:

Treatment with an immune protein called Respiratory Synctial Virus Immune Globulin Intravenous (RSV-IGIV) (Human) appears to be effective in preventing complications associated with lower respiratory infections in high-risk infants. Studies have shown a significant reduction in hospitalization for RSV among premature infants and infants with a lung defect called bronchopulmonary dysplasia. Selected patients should receive an injection before the cold season and monthly during the cold season. One season's therapy can cost between $3,300 and $5,200.

Immunoglobulins, Respiratory syncytial virus infection

---

Treating Alzheimer's Disease with Cholinergic Drugs, Part I

Article Abstract:

Tacrine, first synthesized in 1945, is emerging as a reliable drug for patients with Alzheimer's disease (AD). This drug appears to improve memory functioning. Practitioners considering using tacrine for drug therapy in patients with AD should consider that only 30 to 40% show modest improvement in cognitive functioning, and that the drug costs approximately $1,600 per year in addition to liver function tests and hepatic monitoring.

Alzheimer's disease, Anti-Alzheimer's disease agents, Parasympathomimetic agents, Tacrine

Similar abstracts:

• Abstracts: A comparison of meta-analytic results using literature vs individual patient data: paternal cell immunization for recurrent miscarriage
• Abstracts: Study questions benefit of lowering dietary salt intake. Preserving the mission. School-based clinics offer haven for teens in distress
• Abstracts: The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction
• Abstracts: Neuropathology of the brainstem and spinal cord in end stage rheumatoid arthritis: implications for treatment
• Abstracts: HIV seropositivity rates in outreach-based counseling and testing services: program evaluation. Occasional condom use and HIV risk reduction

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.